NCT05837208

Brief Summary

The aim of the study is to determine:

  • the thickness of the RV4369A truly applied on different areas of the face after single application of the product determined by a multispectral imaging method.
  • the influence of a second application of the product 15 to 30 minutes after the first application on the product thickness determined by multispectral imaging method.
  • the influence of the recommendations of use provided to the subjects before application of the product on the product thickness determined by multispectral imaging method .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 4, 2022

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2022

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 1, 2023

Completed
Last Updated

May 3, 2023

Status Verified

April 1, 2023

Enrollment Period

25 days

First QC Date

April 19, 2023

Last Update Submit

April 28, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Amounts of sun spray applied to the face, measured by multispectral imaging after single application by the subject

    The product quantity applied by the subject (mg/cm2) will be extrapolated from a reference curve build using an image analysis technique

    Visit 1 (Day 1)

  • Amounts of sun spray applied to the face, measured by multispectral imaging after 2 applications by the subject

    The product quantity applied by the subject (mg/cm2) will be extrapolated from a reference curve build using an image analysis technique

    Visit 1 (Day 1)

  • Amounts of sun spray applied to the face, measured by multispectral imaging after 1 application by the subject and according to the recommendations of use provided by the technician

    The product quantity applied by the subject (mg/cm2) will be extrapolated from a reference curve build using an image analysis technique

    Visit 2 (Day 10)

  • Comparisons between measurements of sun spray amounts determined by multispectral imaging

    Comparaisons between an application without recommendations of use (Visit 1), an application without recommendations followed by a second application (Visit 1) and an application according to the recommendations of use (Visit 2)

    Visit 1 (Day1) and visit 2 (Day 10)

Study Arms (1)

Treated Group

all subjects will apply the study product RV4369A

Other: RV4369A cosmetic product

Interventions

The product is applied 1 or 2 times during the 2 study visits. The product is recovered by the technician after application of the product by the volunteer. Application modalities: Inclusion Assessment: The study product is given to the volunteer who applies it to his face (forehead) according to his usual habits. After a waiting time and Multispectral camera measurements, the study product is again applied by the volunteer to his face according to his usual habits. Final assessment: The study product is applied by the Clinical Research Technician on the subject's forearm on 4 delimited areas at specific quantities. After a waiting period and Multispectral camera measurements on the forearm areas, the study product is given to the volunteer who applies it on his face according to the recommendations of use provided by the Technician.

Treated Group

Eligibility Criteria

Age20 Years - 55 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Panel of healthy volonteers

You may qualify if:

  • Dry, normal to combination skin
  • Phototype I to V inclusive.
  • Absence of significant facial hair.

You may not qualify if:

  • Population
  • Pregnant, breastfeeding women.
  • For men: moustached or bearded.
  • Substantial hair on the forearm and face.
  • With scars or other cutaneous characteristics, sunburn on forearms in the test areas, the size of which is considered incompatible with the study.
  • Diseases :
  • Known history of allergy to any of the investigational product ingredients.
  • Known history of allergy to latex.
  • Skin lesions or skin disease on the face or on the arms and forearms that may affect test results (seborrheic dermatitis, atopic dermatitis, psoriasis, acne, rosacea, etc.).
  • Treatments:
  • Ongoing local or Oral treatment (retinoids, anti-inflammatory) that may affect test results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Skin Research Center

Toulouse, France

Location

Study Officials

  • Thérèse Nocera, MD

    Pierre Fabre Dermo Cosmetique

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2023

First Posted

May 1, 2023

Study Start

April 4, 2022

Primary Completion

April 29, 2022

Study Completion

April 29, 2022

Last Updated

May 3, 2023

Record last verified: 2023-04

Locations